Pharmaceutical compositions of cisplatin
US4310515A · kind A · utility
21Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 1979 |
| Grant date | Jan 12, 1982 |
| Priority date | — |
| Expiry date | Oct 1, 1999 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/243
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable, sterile aqueous solution of cisplatin in a sealed container such as an ampul or vial in unit dosage form suitable for intravenous administration to man is provided which has a concentration of cisplatin between about 0.1 and about 1.0 mgm./ml. and a pH in the range of 2.0 to 3.0 or preferably about 2.5. It can also contain sodium chloride and mannitol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.